(Q78192009)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10466859%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

title

Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10466859%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

author name string

H Schouwink

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10466859%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

C M Korse

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10466859%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

J M Bonfrer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10466859%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

A A Hart

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10466859%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

P Baas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10466859%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

publication date

1 July 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10466859%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10466859%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10466859%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10466859%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

page(s)

25-32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10466859%20AND%20SRC:MED&resulttype=core&format=json

Chemotherapy in malignant pleural mesothelioma. A review.

12 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900044-6

7 January 2021

Chemotherapy in malignant mesothelioma: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900044-6

7 January 2021

Malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900044-6

7 January 2021

Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900044-6

7 January 2021

Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900044-6

7 January 2021

Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900044-6

7 January 2021

Survival patterns for malignant mesothelioma: the SEER experience

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900044-6

7 January 2021

Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900044-6

7 January 2021

Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900044-6

7 January 2021

Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900044-6

7 January 2021

A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900044-6

7 January 2021

CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900044-6

7 January 2021

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900044-6

7 January 2021

CA 125: a valid marker in ovarian carcinoma patients treated with paclitaxel?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900044-6

7 January 2021

10.1016/S0169-5002(99)00044-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10466859%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference